This strategy has been effective both preclinically and clinically in other monogenetic diseases including CALD, MLD, MPS, AS, SYNGAP1, and Tay-Sachs/Sandhoff disease. This evidence concerns the gene SYNGAP1 and mucopolysaccharidosis.